BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22812502)

  • 1. Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis.
    Sullivan C; Murphy JM; Griffin MD; Porter RM; Evans CH; O'Flatharta C; Shaw G; Barry F
    Arthritis Res Ther; 2012 Jul; 14(4):R167. PubMed ID: 22812502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig.
    Sullivan C; Barry F; Ritter T; O'Flatharta C; Howard L; Shaw G; Anegon I; Murphy M
    Stem Cells Dev; 2013 Dec; 22(24):3203-13. PubMed ID: 23895495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice.
    Choi JJ; Yoo SA; Park SJ; Kang YJ; Kim WU; Oh IH; Cho CS
    Clin Exp Immunol; 2008 Aug; 153(2):269-76. PubMed ID: 18713142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6.
    Chen B; Hu J; Liao L; Sun Z; Han Q; Song Z; Zhao RC
    Clin Exp Immunol; 2010 Mar; 159(3):292-302. PubMed ID: 20002448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis.
    Schurgers E; Kelchtermans H; Mitera T; Geboes L; Matthys P
    Arthritis Res Ther; 2010; 12(1):R31. PubMed ID: 20175883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17 down-regulates the immunosuppressive capacity of olfactory ecto-mesenchymal stem cells in murine collagen-induced arthritis.
    Tian J; Rui K; Tang X; Wang W; Ma J; Tian X; Wang Y; Xu H; Lu L; Wang S
    Oncotarget; 2016 Jul; 7(28):42953-42962. PubMed ID: 27356747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow Mesenchymal Stem Cells Decrease the Expression of RANKL in Collagen-Induced Arthritis Rats via Reducing the Levels of IL-22.
    Li F; Li X; Liu G; Gao C; Li X
    J Immunol Res; 2019; 2019():8459281. PubMed ID: 31828174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.
    Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z
    Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis.
    Luz-Crawford P; Ipseiz N; Espinosa-Carrasco G; Caicedo A; Tejedor G; Toupet K; Loriau J; Scholtysek C; Stoll C; Khoury M; Noël D; Jorgensen C; Krönke G; Djouad F
    Ann Rheum Dis; 2016 Dec; 75(12):2166-2174. PubMed ID: 26964143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment.
    Sun Y; Kong W; Huang S; Shi B; Zhang H; Chen W; Zhang H; Zhao C; Tang X; Yao G; Feng X; Sun L
    Clin Exp Rheumatol; 2017; 35(2):288-295. PubMed ID: 28094754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis.
    Bouffi C; Bony C; Courties G; Jorgensen C; Noël D
    PLoS One; 2010 Dec; 5(12):e14247. PubMed ID: 21151872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis.
    Yu Y; Yoon KA; Kang TW; Jeon HJ; Sim YB; Choe SH; Baek SY; Lee S; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Jul; 13(7):1134-1142. PubMed ID: 30959558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
    Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
    J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells.
    Park KH; Mun CH; Kang MI; Lee SW; Lee SK; Park YB
    Cell Transplant; 2016; 25(6):1057-72. PubMed ID: 25853338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell source-dependent in vivo immunosuppressive properties of mesenchymal stem cells derived from the bone marrow and synovial fluid of minipigs.
    Lee WJ; Hah YS; Ock SA; Lee JH; Jeon RH; Park JS; Lee SI; Rho NY; Rho GJ; Lee SL
    Exp Cell Res; 2015 May; 333(2):273-288. PubMed ID: 25819273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.
    Djouad F; Fritz V; Apparailly F; Louis-Plence P; Bony C; Sany J; Jorgensen C; Noël D
    Arthritis Rheum; 2005 May; 52(5):1595-603. PubMed ID: 15880818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model.
    Haikal SM; Abdeltawab NF; Rashed LA; Abd El-Galil TI; Elmalt HA; Amin MA
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.